Highlights Novartis AG

Equities

NOVN

CH0012005267

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 10:01:15 20/01/2026 pm IST			5-day change	1st Jan Change
114.26 ^CHF	-1.12%		+0.55%	+4.25%

20/01	Global drugmakers rush to boost US presence as tariff threat looms	RE
20/01	Novartis Seen Largely Shielded From US Tariffs	MT

Highlights

20/01	GSK makes $2.2 billion swoop for RAPT Therapeutics' food allergy drug	RE
19/01	Switzerland's Novartis Secures US FDA Breakthrough Designation for Sjögren's Candidate Ianalumab	MT
18/01	Novartis Lands US FDA Breakthrough Therapy Classification for Ianalumab in Sjögren's Disease	MT
16/01	Novartis Ianalumab Receives Fda Breakthrough Therapy Designation for Sjogren's Disease	CI
13/01	Travere shares fall as US FDA extends review of rare kidney disease drug	RE
13/01	Novartis eyes more bolt-on acquisitions, CEO says	RE
13/01	Novartis Saudi Partners with Saudi Scientific Organization on Chronic Urticaria Awareness Campaign	MT
12/01	Novartis eyes more bolt-on acquisitions, CEO says	RE
12/01	Novartis to Do Value-Creating Bolt-Ons	CI
12/01	SciNeuro, Novartis sign $1.7 billion licensing deal to develop Alzheimer's drugs	RE
09/01	Novartis to Develop New US Radioligand Therapy Manufacturing Site in Florida	MT
09/01	Novartis to Build RLT Manufacturing Facility in Florida	MT
09/01	Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida	RE
09/01	Novartis to Add Radioligand Therapy Manufacturing Facility in Winter Park, Florida, Fourth in US to Serve Patients and Advance $23 Billion Investment	CI
05/01	OKYO Pharma Limited Announces Chief Executive Officer Changes, Effective January 5, 2026	CI
30/12	Chengdu Xingrui Jingxuan Therapeutics Company Limited Initiates Phase I Clinical Trial of theranostics Radiopharmaceutical Project SRT-007 in China	CI
26/12	Singapore's Factory Output Rises in November	MT
24/12	Vor Biopharma Inc Announces Board Appointments, Effective December 18, 2025	CI
21/12	Novartis' Spinal Muscular Atrophy Treatment Wins UAE Regulatory Nod	MT
21/12	Novartis Agrees to Trim Drug Prices in US Amid Investment Push	MT
20/12	Sector Update: Health Care Stocks Rise Late Afternoon	MT
20/12	Trump Reportedly Strikes Drug Price Deals With Nine Pharma Companies	MT
20/12	Novartis and US government reach agreement on lowering drug prices in the US	RE
20/12	Novartis and US Government Reach Agreement on Lower Drug Prices in the US	CI
18/12	Takeda's AI-crafted psoriasis pill succeeds in late-stage studies	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Filters

Headlines

Novartis target price raised after upgrades

December 05, 2025 at 09:53 pm IST

Novartis CEO Says They Will Have to 'Tackle Rhetoric' in US Healthcare

January 21, 2025 at 04:26 pm IST